Commonwealth Equity Services
BIVV

Commonwealth Equity Services’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Commonwealth Equity Services’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-13,555
Closed -$731K – 2830
2017
Q4 		$731K Buy
13,555
+2,621
+24% +$143K ﹤0.01% 1415
2017
Q3 		$624K Sell
10,934
-758
-6% -$44.4K ﹤0.01% 1471
2017
Q2 		$704K Sell
11,692
-2,668
-19% -$152K ﹤0.01% 1341
2017
Q1 		$782K Buy
+14,360
New +$707K 0.01% 1247

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Commonwealth Equity Services's BIVV Position: Q1 2018 in Review

Commonwealth Equity Services sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 13,555 shares — an estimated $731K sold.

Commonwealth Equity Services first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $782K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Commonwealth Equity Services reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Commonwealth Equity Services sold 13,555 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $731K.
  • Commonwealth Equity Services first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Commonwealth Equity Services's Bioverativ Inc. Common Stock position peaked at $782K in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Commonwealth Equity Services's 13F filing for Q1 2018, filed 14 May 2018.